1
|
Gončuková Z, Řezanka M, Dolina J, Dvořák L. Sulfonated polyethersulfone membrane doped with ZnO-APTES nanoparticles with antimicrobial properties. REACT FUNCT POLYM 2021. [DOI: 10.1016/j.reactfunctpolym.2021.104872] [Citation(s) in RCA: 6] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
|
2
|
Li QS, Li Y, Deora GS, Ruan BF. Derivatives and Analogues of Resveratrol: Recent Advances in Structural Modification. Mini Rev Med Chem 2019; 19:809-825. [DOI: 10.2174/1389557519666190128093840] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/16/2018] [Revised: 10/05/2018] [Accepted: 01/09/2019] [Indexed: 12/13/2022]
Abstract
Resveratrol is a non-flavonoid polyphenol containing a terpenoid backbone. It has been intensively studied because of its various promising biological properties, such as anticancer, antioxidant, antibacterial, neuroprotective and anti-inflammatory activities. However, the medicinal application of resveratrol is constrained by its poor bioavailability and stability. In the past decade, more attention has been focused on making resveratrol derivatives to improve its pharmacological activities and pharmacokinetics. This review covers the literature published over the past 15 years on synthetic analogues of resveratrol. The emphasis is on the chemistry of new compounds and relevant biological activities along with structure-activity relationship. This review aims to provide a scientific and reliable basis for the development of resveratrol-based clinical drugs.
Collapse
Affiliation(s)
- Qing-Shan Li
- School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009, China
| | - Yao Li
- School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009, China
| | - Girdhar Singh Deora
- Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria 3052, Australia
| | - Ban-Feng Ruan
- School of Biological and Medical Engineering, Hefei University of Technology, Hefei, 230009, China
| |
Collapse
|
3
|
Mihailović N, Marković V, Matić IZ, Stanisavljević NS, Jovanović ŽS, Trifunović S, Joksović L. Synthesis and antioxidant activity of 1,3,4-oxadiazoles and their diacylhydrazine precursors derived from phenolic acids. RSC Adv 2017. [DOI: 10.1039/c6ra28787e] [Citation(s) in RCA: 40] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
Eight 1,3,4-oxadiazoles and eight of their diacylhydrazine precursors were synthesized and examined for their antioxidative potential using different tests.
Collapse
Affiliation(s)
- Nevena Mihailović
- Faculty of Science
- Department of Chemistry
- University of Kragujevac
- 34000 Kragujevac
- Serbia
| | - Violeta Marković
- Faculty of Science
- Department of Chemistry
- University of Kragujevac
- 34000 Kragujevac
- Serbia
| | - Ivana Z. Matić
- Institute of Oncology and Radiology of Serbia
- 11000 Belgrade
- Serbia
| | | | - Živko S. Jovanović
- Institute of Molecular Genetics and Genetic Engineering
- University of Belgrade
- 11000 Belgrade
- Serbia
| | | | - Ljubinka Joksović
- Faculty of Science
- Department of Chemistry
- University of Kragujevac
- 34000 Kragujevac
- Serbia
| |
Collapse
|
4
|
Romero MA, González-Delgado JA, Arteaga JF. Synthesis of Stilbene Derivatives: A Comparative Study of their Antioxidant Activities. Nat Prod Commun 2015. [DOI: 10.1177/1934578x1501000731] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
A series of structurally simple compounds belonging to thestilbene family were synthesized by means of a Ti(III)-mediated methodology that allows access, in an efficient manner, to derivatives of dihydrostilbene, E-stilbene, and stilbene oxide, with high yields. The antioxidant activity of these compounds has been evaluated by means of two electrochemical assays, which provide complementary information, showing that the majority of these stilbene analogs exhibit significant antioxidant activity dependent on the electronic structure and functionalization of the molecule in each case.
Collapse
Affiliation(s)
- Miguel A. Romero
- CIQSO - Center for Research in Sustainable Chemistry and Department of Chemical Engineering, Physical Chemistry, and Organic Chemistry, University of Huelva, Campus de El Carmen s/n, 21071 Huelva, Spain
| | - José A. González-Delgado
- CIQSO - Center for Research in Sustainable Chemistry and Department of Chemical Engineering, Physical Chemistry, and Organic Chemistry, University of Huelva, Campus de El Carmen s/n, 21071 Huelva, Spain
| | - Jesús F. Arteaga
- CIQSO - Center for Research in Sustainable Chemistry and Department of Chemical Engineering, Physical Chemistry, and Organic Chemistry, University of Huelva, Campus de El Carmen s/n, 21071 Huelva, Spain
| |
Collapse
|
5
|
Jacques SA, Kuhn I, Koniev O, Schuber F, Lund FE, Wagner A, Muller-Steffner H, Kellenberger E. Discovery of Potent Inhibitors of Schistosoma mansoni NAD⁺ Catabolizing Enzyme. J Med Chem 2015; 58:3582-92. [PMID: 25803425 DOI: 10.1021/acs.jmedchem.5b00203] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Abstract
The blood fluke Schistosoma mansoni is the causative agent of the intestinal form of schistosomiasis (or bilharzia). Emergence of Schistosoma mansoni with reduced sensitivity to praziquantel, the drug currently used to treat this neglected disease, has underlined the need for development of new strategies to control schistosomiasis. Our ability to screen drug libraries for antischistosomal compounds has been hampered by the lack of validated S. mansoni targets. In the present work, we describe a virtual screening approach to identify inhibitors of S. mansoni NAD(+) catabolizing enzyme (SmNACE), a receptor enzyme suspected to be involved in immune evasion by the parasite at the adult stage. Docking of commercial libraries into a homology model of the enzyme has led to the discovery of two in vitro micromolar inhibitors. Further structure-activity relationship studies have allowed a 3-log gain in potency, accompanied by a largely enhanced selectivity for the parasitic enzyme over the human homologue CD38.
Collapse
Affiliation(s)
- Sylvain A Jacques
- †Laboratoire des Systèmes Chimiques Fonctionnels, MEDALIS Drug Discovery Center, Faculté de Pharmacie, CAMB UMR7199 CNRS/Université de Strasbourg, 67401 Illkirch, France.,‡Laboratoire d'Innovation Thérapeutique, MEDALIS Drug Discovery Center, Faculté de Pharmacie, LIT UMR7200 CNRS/Université de Strasbourg, 74 Route du Rhin, 67401 Illkirch, France
| | - Isabelle Kuhn
- †Laboratoire des Systèmes Chimiques Fonctionnels, MEDALIS Drug Discovery Center, Faculté de Pharmacie, CAMB UMR7199 CNRS/Université de Strasbourg, 67401 Illkirch, France
| | - Oleksandr Koniev
- †Laboratoire des Systèmes Chimiques Fonctionnels, MEDALIS Drug Discovery Center, Faculté de Pharmacie, CAMB UMR7199 CNRS/Université de Strasbourg, 67401 Illkirch, France
| | - Francis Schuber
- †Laboratoire des Systèmes Chimiques Fonctionnels, MEDALIS Drug Discovery Center, Faculté de Pharmacie, CAMB UMR7199 CNRS/Université de Strasbourg, 67401 Illkirch, France
| | - Frances E Lund
- §Department of Microbiology, University of Alabama at Birmingham, 276 BBRB Box 11, 1720 Second Avenue South, Birmingham Alabama 35294, United States
| | - Alain Wagner
- †Laboratoire des Systèmes Chimiques Fonctionnels, MEDALIS Drug Discovery Center, Faculté de Pharmacie, CAMB UMR7199 CNRS/Université de Strasbourg, 67401 Illkirch, France
| | - Hélène Muller-Steffner
- †Laboratoire des Systèmes Chimiques Fonctionnels, MEDALIS Drug Discovery Center, Faculté de Pharmacie, CAMB UMR7199 CNRS/Université de Strasbourg, 67401 Illkirch, France
| | - Esther Kellenberger
- ‡Laboratoire d'Innovation Thérapeutique, MEDALIS Drug Discovery Center, Faculté de Pharmacie, LIT UMR7200 CNRS/Université de Strasbourg, 74 Route du Rhin, 67401 Illkirch, France
| |
Collapse
|
6
|
van der Made SM, Plat J, Mensink RP. Resveratrol does not influence metabolic risk markers related to cardiovascular health in overweight and slightly obese subjects: a randomized, placebo-controlled crossover trial. PLoS One 2015; 10:e0118393. [PMID: 25790328 PMCID: PMC4366169 DOI: 10.1371/journal.pone.0118393] [Citation(s) in RCA: 95] [Impact Index Per Article: 10.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/11/2014] [Accepted: 01/04/2015] [Indexed: 11/19/2022] Open
Abstract
Background In vitro and animal studies have shown positive effects of resveratrol on lipid and lipoprotein metabolism, but human studies specifically designed to examine these effects are lacking. Objective The primary outcome parameter of this study in overweight and slightly obese subjects was the effect of resveratrol on apoA-I concentrations. Secondary outcome parameters were effects on other markers of lipid and lipoprotein metabolism, glucose metabolism, and markers for inflammation and endothelial function. Design This randomized, placebo-controlled crossover study was conducted in 45 overweight and slightly obese men (n = 25) and women (n = 20) with a mean age of 61 ± 7 years. Subjects received in random order resveratrol (150 mg per day) or placebo capsules for 4 weeks, separated by a 4-week wash-out period. Fasting blood samples were collected at baseline and at the end of each intervention period. Results Compliance was excellent as indicated by capsule count and changes in resveratrol and dihydroresveratrol concentrations. No difference between resveratrol and placebo was found in any of the fasting serum or plasma metabolic risk markers (mean ± SD for differences between day 28 values of resveratrol vs. placebo: apoA-I; 0.00 ± 0.12 g/L (P = 0.791), apoB100; -0.01 ± 0.11 g/L (P = 0.545), HDL cholesterol; 0.00 ± 0.09 mmol/L (P = 0.721), LDL cholesterol -0.03 ± 0.57 mmol/L (P = 0.718), triacylglycerol; 0.10 ± 0.54 mmol/L (P = 0.687), glucose; -0.08 ± 0.28 mmol/L (P = 0.064), insulin; -0.3 ± 2.5 mU/L (P = 0.516)). Also, no effects on plasma markers for inflammation and endothelial function were observed. No adverse events related to resveratrol intake were observed. Conclusion 150 mg of daily resveratrol intake for 4 weeks does not change metabolic risk markers related to cardiovascular health in overweight and slightly obese men and women. Effects on glucose metabolism warrant further study. Trial Registration ClinicalTrials.gov NCT01364961
Collapse
Affiliation(s)
- Sanne M. van der Made
- Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht,The Netherlands
- Top Institute of Food and Nutrition (TIFN), Wageningen, The Netherlands
| | - Jogchum Plat
- Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht,The Netherlands
| | - Ronald P. Mensink
- Department of Human Biology, NUTRIM School for Nutrition, Toxicology and Metabolism, Maastricht University Medical Center, Maastricht,The Netherlands
- Top Institute of Food and Nutrition (TIFN), Wageningen, The Netherlands
- * E-mail:
| |
Collapse
|
7
|
Wangngae S, Duangkamol C, Pattarawarapan M, Phakhodee W. Significance of reagent addition sequence in the amidation of carboxylic acids mediated by PPh3 and I2. RSC Adv 2015. [DOI: 10.1039/c5ra03184b] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022] Open
Abstract
The outcome of the amidation reaction mediated by PPh3–I2 was found to be highly dependent on the addition sequence of the reagents.
Collapse
Affiliation(s)
- Sirilak Wangngae
- Department of Chemistry and Center of Excellence for Innovation in Chemistry
- Faculty of Science
- Chiang Mai University
- Chiang Mai 50200
- Thailand
| | - Chuthamat Duangkamol
- Department of Chemistry and Center of Excellence for Innovation in Chemistry
- Faculty of Science
- Chiang Mai University
- Chiang Mai 50200
- Thailand
| | - Mookda Pattarawarapan
- Department of Chemistry and Center of Excellence for Innovation in Chemistry
- Faculty of Science
- Chiang Mai University
- Chiang Mai 50200
- Thailand
| | - Wong Phakhodee
- Department of Chemistry and Center of Excellence for Innovation in Chemistry
- Faculty of Science
- Chiang Mai University
- Chiang Mai 50200
- Thailand
| |
Collapse
|
8
|
Aldawsari FS, Elshenawy OH, El Gendy MAM, Aguayo-Ortiz R, Baksh S, El-Kadi AOS, Velázquez-Martínez CA. Design and synthesis of resveratrol–salicylate hybrid derivatives as CYP1A1 inhibitors. J Enzyme Inhib Med Chem 2014; 30:884-95. [DOI: 10.3109/14756366.2014.979347] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Fahad S. Aldawsari
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada,
| | - Osama H. Elshenawy
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada,
| | - Mohamed A. M. El Gendy
- Experimental Oncology Unit, Department of Oncology, University of Alberta, Edmonton, Alberta, Canada,
- Department of Pharmacognosy, Pharmaceutical Sciences Division, Natural Research Centre, Dokki, Giza, Egypt,
| | - Rodrigo Aguayo-Ortiz
- Facultad de Química, Departamento de Farmacia, Universidad Nacional Autónoma de México, México,
| | - Shairaz Baksh
- Department of Pediatrics, Oncology and Biochemistry, University of Alberta, Edmonton, Alberta, Canada, and
- Alberta Inflammatory Bowel Disease Consortium, Alberta, Canada
| | - Ayman O. S. El-Kadi
- Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta, Canada,
| | | |
Collapse
|
9
|
Rivera H, Morales-Ríos MS, Bautista W, Shibayama M, Tsutsumi V, Muriel P, Pérez-Álvarez V. A novel fluorinated stilbene exerts hepatoprotective properties in CCl4-induced acute liver damage. Can J Physiol Pharmacol 2011; 89:759-66. [DOI: 10.1139/y11-074] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
There has been a recently increase in the development of novel stilbene-based compounds with in vitro anti-inflamatory properties. For this study, we synthesized and evaluated the anti-inflammatory properties of 2 fluorinated stilbenes on carbon tetrachloride (CCl4)-induced acute liver damage. To achieve this, CCl4 (4 g·kg–1, per os) was administered to male Wistar rats, followed by either 2-fluoro-4′-methoxystilbene (FME) or 2,3-difluoro-4′-methoxystilbene (DFME) (10 mg·kg–1, per os). We found that although both of the latter compounds prevented cholestatic damage (γ-glutamyl transpeptidase activity), only DFME showed partial but consistent results in the prevention of necrosis, as assessed by both alanine aminotransferase activity and histological analysis. Since inflammatory responses are mediated by cytokines, mainly tumour necrosis factor α (TNF-α), we used the Western blot technique to determine the action of FME and DFME on the expression level of this cytokine. The observed increase in the level of TNF-α caused by CCl4 administration was only prevented by treatment with DFME, in agreement with our biochemical findings. This result was confirmed by measuring interleukin-6 (IL-6) levels, since the expression of this protein depends on the level of TNF-α. In this case, DFME completely blocked the CCl4-induced increase of IL-6. Our results suggest that DFME possesses greater anti-inflammatory properties in vivo than FME. DFME constitutes a possible therapeutic agent for liver disease and could serve as a template for structure optimization.
Collapse
Affiliation(s)
- Horacio Rivera
- Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, México, D. F. 07360 Mexico
| | - Martha S. Morales-Ríos
- Departamento de Química, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, México, D. F. 07360 Mexico
| | - Wendy Bautista
- Department of Physiology, University of Manitoba, Winnipeg, MB R3E OJ9, Canada
| | - Mineko Shibayama
- Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, México, D. F. 07360, Mexico
| | - Víctor Tsutsumi
- Departamento de Infectómica y Patogénesis Molecular, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, México, D. F. 07360, Mexico
| | - Pablo Muriel
- Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, México, D. F. 07360 Mexico
| | - Víctor Pérez-Álvarez
- Departamento de Farmacología, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Apartado 14-740, México, D. F. 07360 Mexico
| |
Collapse
|